ghk-cu peptide therapy in centennial co Copper GHK-CU – Research Peptide |

Recent neuroimaging studies and behavioral research have illuminated how pleasure-seeking behaviors can paradoxically reduce motivation for challenging tasks

FDA has also cautioned against compounded drugs containing BPC-157 due to safety risks and potential contamination with other substances

Alzheimer Dement

In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, i.e., its evidence to establish safety for human use is currently insufficient

Nazwa BPC pochodzi od okrelenia Body Protection Compound , czyli "zwizek ochronny organizmu"

Serious and rarer side effects can include muscle cramping, irregular heartbeat, shortness of breath, slurred speech, vision changes, chest pain and weakness on one side of the body